- Home
- FMST vs CCM Comparison
FMST vs CCM Comparison
Compare FMST & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMST | CCM |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3M | 21.3M |
| IPO Year | 2022 | 2009 |
Fundamental Metrics
Financial Performance| Metric | FMST | CCM |
|---|---|---|
| Price | $0.48 | $4.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 365.7K | 11.8K |
| Earning Date | 11-12-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.42 | $2.79 |
| 52 Week High | $3.97 | $6.80 |
Technical Indicators
Market Signals| Indicator | FMST | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 52.18 |
| Support Level | $0.48 | $2.98 |
| Resistance Level | $0.70 | $4.28 |
| Average True Range (ATR) | 0.08 | 0.51 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 27.06 | 63.47 |
Price Performance
Historical ComparisonAbout FMST Foremost Lithium Resource & Technology Ltd.
Foremost Clean Energy Ltd is an exploration company focused on the identification and development of high potential mineral opportunities in stable jurisdictions. Its Uranium properties includes Eastern Athabasca, and Blue-Sky. Its Lithium properties includes Zoro Lithium Project, JEAN LAKE LITHIUM GOLD PROJECT, Peg North Project, Grass River Claims Project, and JOL LITHIUM PROJECT.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.